Comparison of On-Site Versus Off-Site Evaluation of Cholangioscopy-Guided Biopsies of the Bile Duct
Primary Purpose
Bile Duct Stricture
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
on-site specimen evaluation
off-site specimen evaluation
Sponsored by
About this trial
This is an interventional diagnostic trial for Bile Duct Stricture
Eligibility Criteria
Inclusion Criteria:
- Age > 18 years
- Suspected biliary stricture
Exclusion Criteria:
- Age < 18 years
- Pregnancy
- Altered surgical anatomy
- Irreversible elevation in INR > 1.5 or low platelet count < 50,000
Sites / Locations
- AdventHealth Orlando
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
on-site evaluation of specimens by cytopathologist
off-site specimen evaluation
Arm Description
The specimen will be evaluated onsite by a cytopathologist during the procedure to render a diagnosis
The specimen will be evaluated offsite by a cytopathologist during the procedure and render a diagnosis
Outcomes
Primary Outcome Measures
Diagnostic accuracy of cholangioscopy-directed biopsies of bile duct strictures
The primary endpoint of the study is to compare the diagnostic accuracy rates between two different methods used for processing specimens obtained from the bile duct.
Secondary Outcome Measures
Specimen evaluation
The secondary endpoint of the study is for specimen evaluation results deemed as malignant; benign; suspicious; atypical, or non-diagnostic.
Operating characteristics
The secondary endpoint of the study is to assess the operating characteristics through review of the sensitivity, specificity, negative predictive value and positive predictive value between the on-site group and the off-site group.
Costs difference between the onsite and offsite procedures
The secondary endpoint of the study is to review and compare total costs of the onsite group in comparison to the total costs of the off-site group.
Number of biopsies to achieve diagnosis
The secondary endpoint of the study is to compare between on-site and off-site specimen for the number of biopsies to achieve diagnosis
Full Information
NCT ID
NCT01815619
First Posted
February 26, 2013
Last Updated
August 2, 2023
Sponsor
AdventHealth
Collaborators
University of Alabama at Birmingham
1. Study Identification
Unique Protocol Identification Number
NCT01815619
Brief Title
Comparison of On-Site Versus Off-Site Evaluation of Cholangioscopy-Guided Biopsies of the Bile Duct
Official Title
Single-operator Cholangioscopy-guided Biopsy of Bile Duct Strictures: Randomized Trial of Evaluation of Specimens (SOCRATES)
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
February 2013 (undefined)
Primary Completion Date
April 2020 (Actual)
Study Completion Date
August 25, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
AdventHealth
Collaborators
University of Alabama at Birmingham
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will test two different methods for processing biopsy specimens taken from the bile duct. Patient;s who are asked to participate int his study have a stricture in the bile duct that needs a single operator cholangioscopy-guided biopsies during endoscopic retrograde cholangiopancreatography (ERCP) so that a diagnosis can be made. Standard of care includes performing single operator cholangioscopy-guided biopsies in the bile duct and sending the tissue to the lab for testing to make a diagnosis. Using this method the investigators can establish a diagnosis only about 50% of the time. The investigators believe that if a cytopathologist is available in the endoscopy suite during the procedure to evaluate the biopsy specimens onsite, the investigators can improve the diagnostic accuracy. The purpose of this study is to compare two methods for processing biopsies obtained from the bile duct (Onsite vs. Offsite).
Detailed Description
The diagnostic accuracy rate of single operator cholangioscopy-guided biopsy is only 50%. This translates to the need for performing repeat procedures to establish a diagnosis and therefore delays patient treatment. The biopsy specimen obtained at cholangioscopy are usually processed offsite in the pathology lab. We believe that if a pathologist can assess the tissue sample during the procedure itself (onsite) and provide feedback, the diagnostic accuracy rate will improve. This translates to better (faster) diagnosis and early treatment. Therefore, we will be comparing onsite versus offsite evaluation of bile duct biopsy specimens to determine which method yields a better diagnosis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bile Duct Stricture
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
62 (Actual)
8. Arms, Groups, and Interventions
Arm Title
on-site evaluation of specimens by cytopathologist
Arm Type
Experimental
Arm Description
The specimen will be evaluated onsite by a cytopathologist during the procedure to render a diagnosis
Arm Title
off-site specimen evaluation
Arm Type
Active Comparator
Arm Description
The specimen will be evaluated offsite by a cytopathologist during the procedure and render a diagnosis
Intervention Type
Other
Intervention Name(s)
on-site specimen evaluation
Intervention Description
The specimen will be evaluated on-site by a cytopathologist during the procedure to render a diagnosis
Intervention Type
Other
Intervention Name(s)
off-site specimen evaluation
Intervention Description
The specimen will be evaluated off-site by a cytopathologist
Primary Outcome Measure Information:
Title
Diagnostic accuracy of cholangioscopy-directed biopsies of bile duct strictures
Description
The primary endpoint of the study is to compare the diagnostic accuracy rates between two different methods used for processing specimens obtained from the bile duct.
Time Frame
up to18 months
Secondary Outcome Measure Information:
Title
Specimen evaluation
Description
The secondary endpoint of the study is for specimen evaluation results deemed as malignant; benign; suspicious; atypical, or non-diagnostic.
Time Frame
up to18 months
Title
Operating characteristics
Description
The secondary endpoint of the study is to assess the operating characteristics through review of the sensitivity, specificity, negative predictive value and positive predictive value between the on-site group and the off-site group.
Time Frame
up to18 months
Title
Costs difference between the onsite and offsite procedures
Description
The secondary endpoint of the study is to review and compare total costs of the onsite group in comparison to the total costs of the off-site group.
Time Frame
up to 18 months
Title
Number of biopsies to achieve diagnosis
Description
The secondary endpoint of the study is to compare between on-site and off-site specimen for the number of biopsies to achieve diagnosis
Time Frame
up to 18 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
89 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age > 18 years
Suspected biliary stricture
Exclusion Criteria:
Age < 18 years
Pregnancy
Altered surgical anatomy
Irreversible elevation in INR > 1.5 or low platelet count < 50,000
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shyam Varadarajulu, MD
Organizational Affiliation
AdventHealth
Official's Role
Principal Investigator
Facility Information:
Facility Name
AdventHealth Orlando
City
Orlando
State/Province
Florida
ZIP/Postal Code
32803
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
31351135
Citation
Bang JY, Navaneethan U, Hasan M, Sutton B, Hawes R, Varadarajulu S. Optimizing Outcomes of Single-Operator Cholangioscopy-Guided Biopsies Based on a Randomized Trial. Clin Gastroenterol Hepatol. 2020 Feb;18(2):441-448.e1. doi: 10.1016/j.cgh.2019.07.035. Epub 2019 Jul 24.
Results Reference
derived
PubMed Identifier
26995690
Citation
Navaneethan U, Hasan MK, Kommaraju K, Zhu X, Hebert-Magee S, Hawes RH, Vargo JJ, Varadarajulu S, Parsi MA. Digital, single-operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders: a multicenter clinical experience (with video). Gastrointest Endosc. 2016 Oct;84(4):649-55. doi: 10.1016/j.gie.2016.03.789. Epub 2016 Mar 16.
Results Reference
derived
Learn more about this trial
Comparison of On-Site Versus Off-Site Evaluation of Cholangioscopy-Guided Biopsies of the Bile Duct
We'll reach out to this number within 24 hrs